These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11931420)

  • 1. Utility of fluoroquinolones in multidrug-resistant tuberculosis (MDR-TB)--a balanced view?
    Yew WW; Chau CH
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):174-5; author reply 175-6. PubMed ID: 11931420
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Pracharktam R; Angkananukool K; Vibhagool A
    J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
    Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    Umubyeyi AN; Rigouts L; Shamputa IC; Fissette K; Elkrim Y; de Rijk PW; Struelens MJ; Portaels F
    J Antimicrob Chemother; 2007 May; 59(5):1031-3. PubMed ID: 17329272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis.
    Park IN; Hong SB; Oh YM; Lim CM; Lee SD; Lew WJ; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):319-24. PubMed ID: 17352099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
    Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and gatifloxacin against multidrug-resistant Mycobacterium tuberculosis in Rio de Janeiro Brazil.
    Lourenço MC; Junior IN; De Souza MV
    Med Mal Infect; 2007 May; 37(5):295-6. PubMed ID: 17459633
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar.
    Rivoire N; Ravololonandriana P; Rasolonavalona T; Martin A; Portaels F; Ramarokoto H; Rasolofo Razanamparany V
    Int J Tuberc Lung Dis; 2007 Jun; 11(6):683-8. PubMed ID: 17519102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
    Timperi R; Han LL; Sloutsky A; Becerra MC; Nardell EA; Salazar JJ; Smith-Fawzi MC
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rapid development of fluoroquinolone resistance in M. tuberculosis.
    Ginsburg AS; Woolwine SC; Hooper N; Benjamin WH; Bishai WR; Dorman SE; Sterling TR
    N Engl J Med; 2003 Nov; 349(20):1977-8. PubMed ID: 14614180
    [No Abstract]   [Full Text] [Related]  

  • 15. Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.
    Farhat MR; Mitnick CD; Franke MF; Kaur D; Sloutsky A; Murray M; Jacobson KR
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):339-41. PubMed ID: 25686144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.
    Agrawal D; Udwadia ZF; Rodriguez C; Mehta A
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):79-83. PubMed ID: 19105883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [View of development of fluoroquinolones].
    Namba K
    Kekkaku; 1999 Jan; 74(1):47-52. PubMed ID: 10067055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.